Allogene Therapeutics, Inc. (ALLO)
Q2 2020 Earnings Conference Call
August 5, 2020 8:30 AM ET
Company Participants
Christine Cassiano – Chief Communications Officer
David Chang – President and Chief Executive Officer
Rafael Amado – Executive Vice President-Research and Development and Chief Medical Officer
Eric Schmidt – Chief Financial Officer
Conference Call Participants
Phil Nadeau – Cowen and Company
Andrea Tan – Goldman Sachs
Biren Amin – Jefferies
Gavin Scott – JPMorgan
Tyler Van Buren – Piper Sandler
Aaron Welch – H.C. Wainwright
Mark Breidenbach – Oppenheimer
John Newman – Canaccord
Presentation
Operator
Good morning, ladies